Joi B. Carter

Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma

Chrysalyne D. Schmults, Pritesh S. Karia, Joi B. Carter et al. · JAMA Dermatology · 2013 · 550 citations

Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

Rachael A. Clark, Rei Watanabe, Jessica E. Teague et al. · Science Translational Medicine · 2012 · 363 citations

Outcomes of Primary Cutaneous Squamous Cell Carcinoma With Perineural Invasion

Joi B. Carter, Matthew M. Johnson, Tiffany L. Chua et al. · JAMA Dermatology · 2013 · 179 citations

Large-caliber Nerve Invasion, Surgical Oncology, Tumoral Pathology +15

Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma

Jennifer DeSimone, Emmanuella Guenova, Joi B. Carter et al. · Journal of the American Academy of Dermatology · 2013 · 35 citations

Cutaneous T-cell Lymphoma, Low-dose High-dose-rate Brachytherapy, Lymphoid Neoplasia +7

<scp>PD</scp>‐1, S‐100 and <scp>CD1a</scp> expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B‐cell lymphoma (<scp>MALT</scp> lymphoma) and cutaneous lymphoid hyperplasia

Amrita Goyal, Johanna B. Moore, Devon C. Gimbel et al. · Journal of Cutaneous Pathology · 2014 · 29 citations